From: 13th C1-inhibitor deficiency and angioedema workshop—2023
Patients without NASH | Patients with NASH | |
---|---|---|
Previous treatment with attenuated androgens | 23 (51%) | 8 (29%) |
No previous treatment with attenuated androgens | 22 (49%) | 19 (70%) |
BMI median (kg/m2) | 25.62 | 29.12 |
BMI IQR (kg/m2) | 3.97 | 3.77 |
Female patients | 29 (64%) | 13 (48%) |
Male patients | 16 (35%) | 14 (52%) |
Average age (years) | 47.5 | 52.5 |
TOTAL | 45 | 27 |